Appointment booking for Dr. Thomas Kennedy, MD is currently not available.Dr. Thomas Kennedy, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Thomas Kennedy, MD (he/him) is a Internist in Anchorage, AK with over 18 years of experience. What is your opinion of Dr. Thomas Kennedy, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Kennedy, MD has received over $3,553 which includes payments from the following companies:
$628.20 from EMD Serono, Inc.
$505.22 from Teva Pharmaceuticals USA, Inc.
$317.65 from Allergan Inc.
$298.61 from Neurocrine Biosciences, Inc.
$208.15 from UCB, Inc.
$201.49 from GENZYME CORPORATION
$141.34 from AbbVie, Inc.
$125.00 from Amgen Inc.
$101.05 from Intersect ENT, Inc.
$99.42 from Mallinckrodt LLC
$94.46 from LivaNova USA, Inc.
$89.33 from Cyberonics, Inc.
$84.86 from Novartis Pharmaceuticals Corporation
$80.25 from Lundbeck LLC
$68.14 from Supernus Pharmaceuticals, Inc.
$62.35 from Jazz Pharmaceuticals Inc.
$58.80 from Sunovion Pharmaceuticals Inc.
$54.18 from ACADIA Pharmaceuticals Inc
$51.65 from Abbott Laboratories
$41.55 from Grifols USA, LLC
Payments received by Dr. Thomas Kennedy, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!